Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
Cardiovascular Diseases | 0.830 | 1.000 | 6 | 2011 | 2018 | |||||||
|
0.732 | 0.160 | 6 | 160540105 | missense variant | T/C | snv | 5.6E-02 | 3.1E-02 |
|
Cardiovascular Diseases | 0.820 | 1.000 | 4 | 2011 | 2013 | ||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
Nutritional and Metabolic Diseases; Cardiovascular Diseases | 0.820 | 1.000 | 2 | 2013 | 2019 | |||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
0.800 | 1.000 | 6 | 2012 | 2019 | ||||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
0.800 | 1.000 | 4 | 2012 | 2019 | ||||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
Cardiovascular Diseases | 0.770 | 0.875 | 8 | 2012 | 2019 | |||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.710 | 1.000 | 2 | 2013 | 2015 | |||||||
|
0.925 | 0.040 | 6 | 160548706 | intron variant | C/G | snv | 0.44 | 0.42 |
|
Cardiovascular Diseases | 0.710 | 1.000 | 2 | 2009 | 2012 | ||||||
|
1.000 | 0.040 | 6 | 160585045 | splice donor variant | C/A;T | snv | 1.2E-05; 4.1E-02 |
|
Cardiovascular Diseases | 0.710 | 1.000 | 2 | 2014 | 2018 | |||||||
|
0.925 | 0.040 | 6 | 160541471 | intron variant | T/C | snv | 0.13 |
|
Cardiovascular Diseases | 0.710 | 1.000 | 2 | 2009 | 2013 | |||||||
|
0.925 | 0.040 | 6 | 160541471 | intron variant | T/C | snv | 0.13 |
|
Cardiovascular Diseases | 0.710 | 1.000 | 2 | 2009 | 2012 | |||||||
|
0.925 | 0.080 | 6 | 160576086 | intron variant | A/G;T | snv |
|
Cardiovascular Diseases | 0.710 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.040 | 6 | 160584578 | intron variant | C/T | snv | 4.5E-02 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 3 | 2015 | 2018 | |||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
0.700 | 1.000 | 2 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 160591981 | intron variant | T/C | snv | 2.8E-02 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2017 | 2018 | |||||||
|
6 | 160584357 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 2 | 2015 | 2018 | |||||||||||
|
1.000 | 0.040 | 6 | 160584578 | intron variant | C/T | snv | 4.5E-02 |
|
0.700 | 1.000 | 2 | 2013 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 160596331 | intron variant | G/A | snv | 3.6E-02 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2018 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 160596331 | intron variant | G/A | snv | 3.6E-02 |
|
0.700 | 1.000 | 2 | 2017 | 2019 | ||||||||
|
1.000 | 0.040 | 6 | 160597142 | intron variant | C/T | snv | 0.63 |
|
0.700 | 1.000 | 2 | 2017 | 2019 | ||||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
Infections; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.662 | 0.320 | 6 | 160589086 | intron variant | A/G | snv | 4.3E-02 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 |